<?xml version='1.0' encoding='utf-8'?>
<document id="19318600"><sentence text="Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries." /><sentence text="Medication Therapy Management (MTM) is a voluntary patient participation program mandated for Medicare Part D sponsors by the Centers for Medicare and Medicaid Services for chronically ill beneficiaries with high medication costs/utilization" /><sentence text="" /><sentence text="To assess the impact of an MTM program on mortality, healthcare utilization, and prescription medication costs and to quantify drug-related problems (DRPs) identified during MTM" /><sentence text="" /><sentence text="This nonrandomized controlled study was conducted among beneficiaries who were targeted for MTM in 2006" /><sentence text=" The MTM intervention was designed to identify potential DRPs, educate the patient/caregiver about appropriate medication use, and ensure that the patient was appropriately integrated into clinical services" /><sentence text=" Data were collected from administrative databases and manual chart abstractions" /><sentence text=" Study outcomes included all-cause death (primary outcome), hospitalization, and emergency department (ED) visit rates and medication cost changes in the 180 days following MTM targeting and quantification of DRPs" /><sentence text=" Multivariate logistic regression was used to adjust the outcomes for baseline risk and other potential confounders" /><sentence text=" A mock MTM intervention was performed for beneficiaries who declined MTM and died, were hospitalized, and/or made an ED visit" /><sentence text="" /><sentence text="A total of 459 opt-in and 336 opt-out beneficiaries who agreed and declined, respectively, to receive MTM were included in the analysis" /><sentence text=" Beneficiaries who opted in were less likely to die compared with beneficiaries who opted out (adjusted OR [AOR] 0" /><sentence text="5; 95% CI 0" /><sentence text="3 to 0" /><sentence text="9) but were more likely to have had a hospitalization (AOR 1" /><sentence text="4; 95% CI 1" /><sentence text="1 to 2" /><sentence text="0) and an increase in medication costs (AOR 1" /><sentence text="4; 95% CI 1" /><sentence text="1 to 1" /><sentence text="9) during follow-up" /><sentence text=" There was no difference in ED visit rates" /><sentence text=" At least one DRP was identified in more than 83% of beneficiaries in both groups, with the most common DRP being drug-drug interaction" /><sentence text="" /><sentence text="Our investigation supports the use of MTM, with its increased coordination of information between healthcare providers and patients, since it may impact mortality positively in a population of high-risk Medicare beneficiaries"><entity charOffset="38-41" id="DDI-PubMed.19318600.s27.e0" text="MTM" /></sentence><sentence text="" /></document>